Tiziana Life Sciences Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -30.0% | +0.0% | -10.0% | +0.0% | +2.9% | +0.0% | +47.1% | +0.0% | -30.7% | +0.0% | |
| – | +0.0% | -51.7% | +0.0% | +5.6% | +0.0% | -3.1% | +0.0% | +69.4% | +0.0% | -32.7% | +0.0% | |
| – | +0.0% | -82.1% | +0.0% | -4.5% | +0.0% | +229.6% | +0.0% | +94.7% | +0.0% | -44.7% | +0.0% | |
| – | +0.0% | -82.1% | +0.0% | -4.5% | +0.0% | +229.6% | +0.0% | +94.7% | +0.0% | – | – | |
| – | -8.0% | -23.3% | +0.0% | +9.4% | -5.4% | -41.1% | +0.0% | +34.0% | +0.0% | – | – | |
| – | +0.0% | +61.2% | +0.0% | +37.0% | +0.0% | -19.3% | +0.0% | +0.7% | +0.0% | +54.7% | +0.0% | |
| – | +0.0% | +66.0% | +0.0% | +38.7% | +0.0% | -19.0% | +0.0% | +0.7% | +0.0% | +51.5% | +0.0% | |
| – | +0.0% | -18.8% | +100.0% | +2.9% | -50.0% | -25.4% | +100.0% | -49.5% | +0.0% | – | – | |
| – | +0.0% | +40.3% | +0.0% | +80.8% | +0.0% | -25.4% | +0.0% | – | – | +37.2% | +0.0% | |
| – | +0.0% | -58.4% | +0.0% | -66.5% | +0.0% | +112.2% | +0.0% | +133.7% | +0.0% | -99.4% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +1.1% | +0.0% | +0.4% | +0.0% | +116.2% | -51.1% | +7.1% | +0.0% | +106.3% | -50.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.